Exact Sciences gains Buy ratings as Cologuard Plus expands in-network Medicare Advantage coverage, boosting reimbursement and revenue potential in cancer screening diagnostics.

CMS is considering a pilot program to cover GLP-1 drugs for obesity under Medicare and Medicaid, reversing earlier policy. This evolving coverage changes obesity drug access for patients and payers.

The Trump administration proposes a Medicare and Medicaid pilot program for covering GLP-1 weight loss drugs, marking a key shift in healthcare policy and potential budget impacts.

Explore the 2026 Medicare payment updates for hospice, rehab, and psychiatric care, hospital efficiency initiatives amid rising costs, and growing use of agentic AI in healthcare settings.

Effective November 2025, Aetna changes Medicare Advantage inpatient admission payments under the Two-Midnight Rule, impacting hospital reimbursements and billing practices.

Study reveals Medicare spends $4.4 billion annually on low-value tests and procedures in older adults, urging evidence-based reforms to reduce waste and enhance care quality.

Explore the latest developments in Medicare for 2025 including UnitedHealthcare's market exits, anticipated drug price increases, new rural hospital funding legislation, and changes to Medicare Savings Programs affecting coverage and costs.

Trump administration's new health data sharing initiative involves major tech companies to improve patient access to health records, focusing on interoperability, AI-driven tools, and data privacy concerns.

The AMA report reveals high market concentration among pharmacy benefit managers (PBMs), vertical integration with insurers, and calls for increased transparency and regulatory reforms to control drug prices and enhance competition.

The AHCA is actively seeking Medicare Advantage data from providers to ensure compliance with prior authorization and regulatory guidelines, while studies reveal key unmet needs pushing seniors with dementia toward nursing homes.